False ID and credit cards cause enormous damage. Working together, Bayer MaterialScience and Bayer Technology Services have developed a forgery-proof card system. » more
Portfolio High-potential subgroups A global enterprise with core competences in the fields of health care, nutrition and high-tech materials» more
Carbon nanotubes High strength, low weight Baytubes® enable lightweight designs and enhanced energy efficiency in many application areas, for example rotor blades for wind turbines. » more » Press Information
Audio Podcast Study of chronic thrombosis therapy Bayer has presented recent study data showing that its new anticoagulant rivaroxaban can substantially reduce the risk of recurrent deep-vein thrombosis or pulmonary embolism.1:10 min.
1:10 min.
Quicklinks
Publications
Links
research – The Bayer Scientific Magazine
